Recipient

Johnson & Johnson Medical Limited

Pin Request correction

First report 18 Mar 2016•Latest report 18 Mar 2016

Recipient record

Reports, concerns and published responses

Private and voluntary organisations · Private limited company. This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.

Reports
1

Naming this recipient

Published responses
0%

Found for named reports

Concerns addressed
0

Across all linked responses

Stated actions
0

Described in responses

Reports over time

Reports over time

Reports naming this recipient by issue year.

Evidence profile

Report topics

Share of this recipient’s reports compared with all other recipients.

0%published responses found
0stated actions described

Topic comparisons are not available in the current evidence snapshot.

Concerns and recipient responses

Statements from Johnson & Johnson Medical Limited linked to the concerns in each report. Select any concern, action or position to view the source wording.

  1. Inner North London

    AI-generated summary

    Rubana PATHAN · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Rubana Pathan was admitted to Homerton University Hospital and was diagnosed with toxic shock syndrome associated with a Staphylococcus aureus infection of an infected breast implant wound. A concern was raised that the absence of pus or localised redness may have contributed to the implant not being recognised as the cause of sepsis, because the responsible toxin can suppress signs of local inflammation.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below. The report was sent to Johnson & Johnson Medical Limited; that does not assign responsibility.

    PFD Monitor interpretation

    Failure to disseminate information that toxins can suppress signs of local inflammation in patients at risk of sepsis

    Wider context from the report

    “Although Ms Pathan’s MENTOR breast implant was suspected as being the cause of her sepsis and was removed on the evening of Saturday, 7 November 2015, her surgeon told me at inquest that she still did not believe this to be the cause, because she found no pus or localised redness. However, one of the treating microbiologists undertook a literature search after Ms Pathan’s death and discovered that the toxin found to be responsible for her illness can supress signs of local inflammation such as the production of pus. Although this is a rare occurrence, it seems to me that the information could usefully be disseminated among those likely to be caring for patients who may be at risk of developing sepsis, both by the hospital and by the implant manufacturer. ”
    Open source report
Back to top

Published response patterns

Compared with other recipients in reports included in PFD Monitor

Describes published response evidence, not performance.

Published responses found

0%
0%All other recipients 58%
0%100%

How actions were described at the time

This respondent
All other recipients
47%25%27%<1%<1%
  • Completed
  • In progress
  • Planned
  • Unclear
  • Partially completed

Statuses reflect what recipients said at the time. PFD Monitor does not verify whether actions happened.

Types of action described in responses

Percentages use all actions described by each group. An action may have more than one type, so percentages do not total 100%.

Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Data last updated 7 September 2026